Cases & Deals

JumpStart invests in Thermalin Diabetes

Clients JumpStart Inc.

Jones Day advised JumpStart Inc. in connection with its purchase of a Secured Convertible Promissory Note in a private placement by Thermalin Diabetes, Incorporated, a developer of portfolios of insulin analogs to address both the fast-acting and long-acting insulin markets.